8625 related articles for article (PubMed ID: 1668725)
1. Tryptophan protects human melanoma cells against gamma-interferon and tumour necrosis factor-alpha: a unifying mechanism of action.
Wood JM; Ehrke C; Schallreuter KU
Melanoma Res; 1991; 1(3):177-85. PubMed ID: 1668725
[TBL] [Abstract][Full Text] [Related]
2. Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha.
Däubener W; Remscheid C; Nockemann S; Pilz K; Seghrouchni S; Mackenzie C; Hadding U
Eur J Immunol; 1996 Feb; 26(2):487-92. PubMed ID: 8617321
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma.
Liebau C; Baltzer AW; Schmidt S; Roesel C; Karreman C; Prisack JB; Bojar H; Merk H
Anticancer Res; 2002; 22(2A):931-6. PubMed ID: 12014674
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide.
Aune TM; Pogue SL
J Clin Invest; 1989 Sep; 84(3):863-75. PubMed ID: 2503544
[TBL] [Abstract][Full Text] [Related]
5. Human recombinant alpha- and gamma-interferons enhance the cytotoxic properties of tumor necrosis factor on human melanoma.
Bregman MD; Meyskens FL
J Biol Response Mod; 1988 Aug; 7(4):384-9. PubMed ID: 3139842
[TBL] [Abstract][Full Text] [Related]
6. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
Hoon DS; Banez M; Okun E; Morton DL; Irie RF
Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway.
Christen S; Thomas SR; Garner B; Stocker R
J Clin Invest; 1994 May; 93(5):2149-58. PubMed ID: 8182147
[TBL] [Abstract][Full Text] [Related]
8. Manganese superoxide dismutase is induced by IFN-gamma in multiple cell types. Synergistic induction by IFN-gamma and tumor necrosis factor or IL-1.
Harris CA; Derbin KS; Hunte-McDonough B; Krauss MR; Chen KT; Smith DM; Epstein LB
J Immunol; 1991 Jul; 147(1):149-54. PubMed ID: 1904900
[TBL] [Abstract][Full Text] [Related]
9. Relationship between cell kinetics and apoptotic effects in TNF-alpha and IFN-gamma-treated human tumour cell lines.
Baisch H
Eur Cytokine Netw; 2001; 12(4):604-13. PubMed ID: 11781187
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of phorbol ester and INF-gamma on the induction of indoleamine 2,3-dioxygenase in THP-1 monocytic leukemia cells.
Edelstein MP; Ozaki Y; Duch DS
J Immunol; 1989 Nov; 143(9):2969-73. PubMed ID: 2553814
[TBL] [Abstract][Full Text] [Related]
11. IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity.
Webb DS; Gerrard TL
J Immunol; 1990 May; 144(9):3643-8. PubMed ID: 2158515
[TBL] [Abstract][Full Text] [Related]
12. NF-kappa B activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-gamma and tumor necrosis factor-alpha.
Robinson CM; Hale PT; Carlin JM
Cytokine; 2006 Jul; 35(1-2):53-61. PubMed ID: 16931033
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of cytokine-induced death of cultured bovine luteal cells.
Petroff MG; Petroff BK; Pate JL
Reproduction; 2001 May; 121(5):753-60. PubMed ID: 11427163
[TBL] [Abstract][Full Text] [Related]
14. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
[TBL] [Abstract][Full Text] [Related]
15. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells.
Babcock TA; Carlin JM
Cytokine; 2000 Jun; 12(6):588-94. PubMed ID: 10843733
[TBL] [Abstract][Full Text] [Related]
18. Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures.
Carlin JM; Borden EC; Sondel PM; Byrne GI
J Immunol; 1987 Oct; 139(7):2414-8. PubMed ID: 2443564
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
Morikawa K; Fidler IJ
J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
Murakami A; Kawabata K; Koshiba T; Gao G; Nakamura Y; Koshimizu K; Ohigashi H
Cancer Res; 2000 Nov; 60(22):6326-31. PubMed ID: 11103793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
